Similar articles for PMID: 20662711

Year	Number of Results
1947	1
1989	1
1990	1
1994	1
1996	2
1997	1
1998	2
1999	1
2000	5
2001	4
2002	3
2003	1
2004	4
2005	4
2006	5
2007	2
2009	3
2010	4
2011	2
2013	2
2014	1
2021	1
2022	2
2024	1

1

Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment.

Ginsberg G, Guyton K, Johns D, Schimek J, Angle K, Sonawane B. Ginsberg G, et al. Crit Rev Toxicol. 2010 Aug;40(7):575-619. doi: 10.3109/10408441003742895. Crit Rev Toxicol. 2010. PMID: 20662711 Review.

2

The influence of genetic polymorphisms on population variability in six xenobiotic-metabolizing enzymes.

Ginsberg G, Smolenski S, Neafsey P, Hattis D, Walker K, Guyton KZ, Johns DO, Sonawane B. Ginsberg G, et al. J Toxicol Environ Health B Crit Rev. 2009;12(5-6):307-33. doi: 10.1080/10937400903158318. J Toxicol Environ Health B Crit Rev. 2009. PMID: 20183525 Review.

3

Genetic polymorphisms in assessing interindividual variability in delivered dose.

Haber LT, Maier A, Gentry PR, Clewell HJ, Dourson ML. Haber LT, et al. Regul Toxicol Pharmacol. 2002 Apr;35(2 Pt 1):177-97. doi: 10.1006/rtph.2001.1517. Regul Toxicol Pharmacol. 2002. PMID: 12052003 Review.

4

[Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].

Ozawa S. Ozawa S. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 1998;(116):69-81. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 1998. PMID: 10097514 Review. Japanese.

5

Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.

Longuemaux S, Deloménie C, Gallou C, Méjean A, Vincent-Viry M, Bouvier R, Droz D, Krishnamoorthy R, Galteau MM, Junien C, Béroud C, Dupret JM. Longuemaux S, et al. Cancer Res. 1999 Jun 15;59(12):2903-8. Cancer Res. 1999. PMID: 10383153

6

Diet, genetic polymorphisms, detoxification, and health risks.

Lampe JW. Lampe JW. Altern Ther Health Med. 2007 Mar-Apr;13(2):S108-11. Altern Ther Health Med. 2007. PMID: 17405687 Review.

7

Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.

Gresner P, Gromadzinska J, Wasowicz W. Gresner P, et al. Lung Cancer. 2007 Jul;57(1):1-25. doi: 10.1016/j.lungcan.2007.02.002. Epub 2007 Mar 6. Lung Cancer. 2007. PMID: 17337085 Review.

8

Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility.

Lacko M, Oude Ophuis MB, Peters WH, Manni JJ. Lacko M, et al. Anticancer Res. 2009 Feb;29(2):753-61. Anticancer Res. 2009. PMID: 19331232 Free article. Review.

9

Human sulfotransferases and their role in chemical metabolism.

Gamage N, Barnett A, Hempel N, Duggleby RG, Windmill KF, Martin JL, McManus ME. Gamage N, et al. Toxicol Sci. 2006 Mar;90(1):5-22. doi: 10.1093/toxsci/kfj061. Epub 2005 Dec 1. Toxicol Sci. 2006. PMID: 16322073 Review.

10

[Biomarkers of gentotoxic risk and metabolic polymorphism].

Pavanello S, Clonfero E. Pavanello S, et al. Med Lav. 2000 Sep-Oct;91(5):431-69. Med Lav. 2000. PMID: 11189784 Review. Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

49 results

Results by year